The article from the World Health Organization (WHO) Regional Office for Africa, titled “Burden of hearing loss in Africa could rise to 54 million by 2030: WHO report,” presents a comprehensive analysis of the “burden of hearing loss in Africa” and its future projections.
Currently, 40 million people in Africa manage hearing loss, and this number will likely grow to 54 million by 2030. Without action, the burden of hearing loss in Africa will rise to 97 million by 2050.
The economic and social impact of hearing loss is significant, costing the continent around $27 billion annually. This issue profoundly affects human lives, delaying language development in children, leading to poor educational outcomes, and limiting career prospects. Furthermore, adults face increased risks of isolation, loneliness, depression, and dementia.
Hearing loss in Africa is exacerbated by several factors, including a severe shortage of ear and hearing care (EHC) specialists, with over 56% of African countries having only one ear, nose, and throat (ENT) specialist per million people, compared to approximately 50 per million in Europe. This workforce is also unevenly distributed, concentrated mainly in urban areas, leaving rural populations underserved. Furthermore, only about 10% of the 33 million Africans in need of hearing aids have access, largely due to high costs and financial barriers.
A significant portion of hearing loss is preventable. Up to 75% of hearing loss in children from low- and middle-income countries results from preventable causes such as infections, common ear diseases, and birth complications. Nonetheless, many countries fail to conduct routine hearing screenings for newborns.
EHC services are often not included in priority health programs like school health, occupational health, or healthy aging initiatives. Many nations lack national policies to strengthen EHC delivery, and those with plans often see low implementation levels. Alarmingly, 35% of countries do not provide a budget for EHC activities, shifting the financial burden onto patients.
The report urges several critical actions:
Overall, the report emphasizes the urgent necessity for comprehensive and integrated strategies to tackle the growing burden of hearing loss in Africa effectively.
🌍 *Could a twice-yearly shot revolutionize HIV prevention?*
Gilead Sciences has submitted key applications to the EMA for lenacapavir, a groundbreaking HIV-1 capsid inhibitor designed for use as pre-exposure prophylaxis (PrEP). With promising trial results indicating a significant reduction in HIV infections, this innovation could enhance adherence to prevention strategies globally. Discover more about this game-changing development!
#SyenzaNews #globalhealth #healthcareInnovation
🌍 Can collaboration redefine Africa’s health landscape?
A newly signed Memorandum of Understanding between Africa CDC and Global Health EDCTP3 promises to enhance health research, clinical trials, and pandemic preparedness on the continent. With a focus on training, local manufacturing, and equitable partnerships, this initiative aims to address pressing global health challenges while improving health outcomes across Africa.
Look into the details of this transformative partnership and its implications for the future of healthcare in the region!
#SyenzaNews #globalhealth #HealthcareInnovation
🚨 Are we doing enough to tackle the imminent breast cancer crisis in Africa?
A recent WHO report reveals alarming trends, predicting that 135,000 women could succumb to breast cancer by 2040 unless urgent actions are taken. The report highlights critical gaps in healthcare infrastructure and capacity, emphasizing the need for investment in screening programs and professional training to improve outcomes across the continent.
Review the full article to explore the necessary steps towards reinforcing breast cancer control measures in Africa.
#SyenzaNews #globalhealth #oncology #HealthTech
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
